摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3,4,6,8,15-Hexahydroxy-10,13-bis-((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyloxymethyl)-dibenzo[a,o]perylene-7,16-dione | 196865-21-1

中文名称
——
中文别名
——
英文名称
1,3,4,6,8,15-Hexahydroxy-10,13-bis-((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyloxymethyl)-dibenzo[a,o]perylene-7,16-dione
英文别名
7,11,13,16,18,22-hexahydroxy-5,24-bis[[(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexyl]oxymethyl]heptacyclo[13.11.1.12,10.03,8.019,27.021,26.014,28]octacosa-1,3(8),4,6,10,12,14(28),15(27),16,18,21(26),22,24-tridecaene-9,20-dione
1,3,4,6,8,15-Hexahydroxy-10,13-bis-((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyloxymethyl)-dibenzo[a,o]perylene-7,16-dione化学式
CAS
196865-21-1
化学式
C50H54O10
mdl
——
分子量
814.973
InChiKey
AHAPJIFZVCAMMN-PHGQXHBGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    10.39
  • 重原子数:
    60.0
  • 可旋转键数:
    8.0
  • 环数:
    9.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    173.98
  • 氢给体数:
    6.0
  • 氢受体数:
    10.0

反应信息

  • 作为反应物:
    描述:
    1,3,4,6,8,15-Hexahydroxy-10,13-bis-((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyloxymethyl)-dibenzo[a,o]perylene-7,16-dione丙酮 为溶剂, 反应 2.0h, 以90%的产率得到1,3,4,6,8,13-Hexahydroxy-10,11-bis-((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyloxymethyl)-phenanthro[1,10,9,8-opqra]perylene-7,14-dione
    参考文献:
    名称:
    Concerning the enantiomerization barrier of hypericin
    摘要:
    The Syntheses of omega-(R)-menthyl and omega,omega-bis-(R)-menthyl derivatives 2 and 3 of hypericin were achieved, and the corresponding diastereomers could be separated. The equilibria between the respective diastereomers are slightly displaced in favor of the chromatographically faster moving ones. Kinetic measurements on these easily equilibrating diastereomers of 2 and 3 provided an Arrhenius activation energy for the interconversion barrier between the two propeller conformers of 83 and 89 kJ/mol. It could be shown that the omega-menthyl residues are of minor relevance to the height of this barrier, as is also the case for the bay hydroxyl ionization and quinone tautomerization equilibria. It was thus concluded that the intrinsic barrier for the propeller conformer enantiomerization of hypericin is in the order of 80 kJ/mol. These results are in accord with those obtained from semiempirical calculations.
    DOI:
    10.1007/bf00810772
  • 作为产物:
    描述:
    1,3,8-triacetoxy-6-iodomethyl-anthraquinone 在 哌啶吡啶吡啶-N-氧化物盐酸硫酸silver trifluoromethanesulfonate三氯化铁 、 tin(ll) chloride 作用下, 以 乙醇溶剂黄146 为溶剂, 反应 26.33h, 生成 1,3,4,6,8,15-Hexahydroxy-10,13-bis-((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyloxymethyl)-dibenzo[a,o]perylene-7,16-dione
    参考文献:
    名称:
    Concerning the enantiomerization barrier of hypericin
    摘要:
    The Syntheses of omega-(R)-menthyl and omega,omega-bis-(R)-menthyl derivatives 2 and 3 of hypericin were achieved, and the corresponding diastereomers could be separated. The equilibria between the respective diastereomers are slightly displaced in favor of the chromatographically faster moving ones. Kinetic measurements on these easily equilibrating diastereomers of 2 and 3 provided an Arrhenius activation energy for the interconversion barrier between the two propeller conformers of 83 and 89 kJ/mol. It could be shown that the omega-menthyl residues are of minor relevance to the height of this barrier, as is also the case for the bay hydroxyl ionization and quinone tautomerization equilibria. It was thus concluded that the intrinsic barrier for the propeller conformer enantiomerization of hypericin is in the order of 80 kJ/mol. These results are in accord with those obtained from semiempirical calculations.
    DOI:
    10.1007/bf00810772
点击查看最新优质反应信息

文献信息

  • Concerning the enantiomerization barrier of hypericin
    作者:R. Altmann、C. Etzlstorfer、H. Falk
    DOI:10.1007/bf00810772
    日期:1997.4
    The Syntheses of omega-(R)-menthyl and omega,omega-bis-(R)-menthyl derivatives 2 and 3 of hypericin were achieved, and the corresponding diastereomers could be separated. The equilibria between the respective diastereomers are slightly displaced in favor of the chromatographically faster moving ones. Kinetic measurements on these easily equilibrating diastereomers of 2 and 3 provided an Arrhenius activation energy for the interconversion barrier between the two propeller conformers of 83 and 89 kJ/mol. It could be shown that the omega-menthyl residues are of minor relevance to the height of this barrier, as is also the case for the bay hydroxyl ionization and quinone tautomerization equilibria. It was thus concluded that the intrinsic barrier for the propeller conformer enantiomerization of hypericin is in the order of 80 kJ/mol. These results are in accord with those obtained from semiempirical calculations.
查看更多

同类化合物

苝-3,10-二酮 竹红菌乙素 痂囊腔菌素A 格孢毒素II 格孢毒素I 抑制剂C 卡弗他丁A 4,9-二羟基-6,7-二(2-羟基丙基)-1,5,8,12-四甲氧基苝-3,10-二酮 1-[3,10-二羟基-12-[2-(4-羟基苯甲酰基)氧基丙基]-2,6,7,11-四甲氧基-4,9-二氧代二萘嵌苯-1-基]丙-2-基4-羟基苯甲酸酯 1-[3,10-二羟基-12-(2-羟基丙基)-2,6,7,11-四甲氧基-4,9-二氧代二萘嵌苯-1-基]丙-2-基苯甲酸酯 (1S,12aR,12bS)-1,2,12a,12b-四氢-1,4,9,12a-四羟基-3,10-苝二酮 Dimethyl 3,10-Dihydro-2,4,6,7,9,11-hexamethoxy-3,10-dioxo-1,12-perylenediacetate Elsinochrome A Alterlosin I 4,10-dihydroxy-5,9-dihydrodinaphtho<2,1-b:1',2'-d>furan-5,9-dione Stemphyltoxin I Acetic acid 6,7,12-triacetoxy-3,10-dihydroxy-4,9-dioxo-4,9-dihydro-perylen-1-yl ester 4,9-Dihydroxy-1,6,7,12-tetramethoxy-perylene-3,10-dione 1,3,4,6,8,15-Hexahydroxy-10,13-bis-((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyloxymethyl)-dibenzo[a,o]perylene-7,16-dione 1,3,4,6,8,15-Hexahydroxy-10-((1R,2S,5R)-2-isopropyl-5-methyl-cyclohexyloxymethyl)-13-methyl-dibenzo[a,o]perylene-7,16-dione Acetic acid 4,9,12-triacetoxy-3,10-dioxo-3,10-dihydro-perylen-1-yl ester Cercosporin, pure 2,11-dihydroxy-4,6,7,9-tetramethoxy-1,12-bis-n-propyl-3,10-perylenequinone 7,19-dihydroxy-5-(2-hydroxypropyl)-21-[(2R)-2-hydroxypropyl]-6,20-dimethoxy-12,14-dioxahexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1,3(8),4,6,10,15,18(23),19,21-nonaene-9,17-dione 2,11-Diamino-perylene-3,10-dione Stemphyltoxin III (3aS)-7,13-dihydroxy-1t,3c,8t,10c-tetramethyl-(3ar,10ac)-1,3,3a,8,10,10a-hexahydro-2,4,9,11-tetraoxa-dibenzo[bc,kl]coronene-6,14-dione [(2S)-1-[3,10-dihydroxy-12-[(2S)-2-(4-hydroxyphenoxy)carbonyloxypropyl]-2,6,7,11-tetramethoxy-4,9-dioxoperylen-1-yl]propan-2-yl] benzoate 2,4,6,7,9,11-hexamethoxy-1,12-bis-propyl-3,10-perylenequinone 6-[1-(9,17-Dihydroxy-5,10,16,21-tetramethoxy-13-methyl-7,19-dioxo-12-hexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaenyl)ethylideneamino]hexane-1-sulfonic acid 1,2,5,6-tetrahydroxy-dibenzo[a,o]perylene-7,16-dione calphostin D Phleichrome calphostin A [6-acetyl-8-(3-acetyl-5,7-diacetyloxy-2-methyl-4-oxo-1H-naphthalen-1-yl)-4-acetyloxy-7-methyl-5-oxo-8H-naphthalen-2-yl] acetate (13S)-12-acetyl-9,13,17-trihydroxy-5,10,16,21-tetramethoxy-13-methylhexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,16,18(23),20-nonaene-7,19-dione 4,9-Dihydroxy-1,5,6,7,8,12-hexamethylperylene-3,10-dione Carbonic acid, 2-(12-(2-(benzoyloxy)propyl)-3,10-dihydro-4,9-dihydroxy-2,6,7,11-tetramethoxy-3,10-dioxo-1-perylenyl)-1-methylethyl 4-hydroxyphenyl ester (-)-Phleichrome 1,3,4,6,8,15-Hexahydroxy-9,14-diisopropyl-10,13-dimethoxy-dibenzo[a,o]perylene-7,16-dione 1,6-dihydroxydibenzoperylene-7,16-dione 5-[1-(9,17-Dihydroxy-5,10,16,21-tetramethoxy-13-methyl-7,19-dioxo-12-hexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaenyl)ethylideneamino]pentane-1-sulfonic acid 4-[1-(9,17-Dihydroxy-5,10,16,21-tetramethoxy-13-methyl-7,19-dioxo-12-hexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaenyl)ethylideneamino]butane-1-sulfonic acid Cercosporin (12R,13S)-12-acetyl-9,16-dihydroxy-13-[(1S)-1-hydroxyethyl]-5,10,15,20-tetramethoxyhexacyclo[12.8.0.02,11.03,8.04,21.017,22]docosa-1(14),2(11),3(8),4(21),5,9,15,17(22),19-nonaene-7,18-dione 10,13-dimethyl-1,3,4,6-tetrahydroxy-helianthrone 12-Acetyl-16-(butylamino)-9,17-dihydroxy-5,10,21-trimethoxy-13-methylhexacyclo[13.8.0.02,11.03,8.04,22.018,23]tricosa-1(15),2(11),3(8),4(22),5,9,12,16,18(23),20-decaene-7,19-dione 5,7,11,13,16,18,22,24-Octahydroxy-6,12,17,23-tetramethyloctacyclo[13.11.1.12,10.03,8.04,25.019,27.021,26.014,28]octacosa-3,5,7,10,12,14(28),15(27),16,18,21,23,25-dodecaene-9,20-dione [(2R)-1-[3,10-dihydroxy-12-[(2S)-2-(4-hydroxyphenoxy)carbonyloxypropyl]-2,6,7,11-tetramethoxy-4,9-dioxoperylen-1-yl]propan-2-yl] benzoate [(2S)-1-[3,10-dihydroxy-12-[(2R)-2-(4-hydroxyphenoxy)carbonyloxypropyl]-2,6,7,11-tetramethoxy-4,9-dioxoperylen-1-yl]propan-2-yl] benzoate